BusinessCogstate Establishes Rare Disease and Pediatric Center of ExcellenceBy Nasdaq OMXApr 5, 2018, 1:16 PM UTC
BusinessBioNews Services Puts Sharp Focus on Rare Disease Day 2018By Nasdaq OMXFeb 28, 2018, 1:45 PM UTC
BusinessHorizon Pharma plc Submits Supplemental New Drug Application for RAVICTI® (glycerol phenylbutyrate) Oral Liquid to Expand Age Range to Include NewbornsBy Nasdaq OMXFeb 27, 2018, 11:00 PM UTC
BusinessHorizon Pharma Gift Establishes First Clinical Team Endowment at Children’s National Rare Disease InstituteBy Nasdaq OMXFeb 26, 2018, 1:02 PM UTC
BusinessHorizon Pharma plc Announces Release of the First RAREis™ Song in Partnership with Sing Me a Story Foundation and Global GenesBy Nasdaq OMXFeb 22, 2018, 2:01 PM UTC
BusinessHorizon Pharma plc Announces the Launch of “Cystinosis United” to Educate, Inspire and Connect the Cystinosis CommunityBy Nasdaq OMXJan 30, 2018, 1:30 PM UTC
BusinessStrongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna ZentarisBy Nasdaq OMXJan 17, 2018, 12:00 PM UTC
BusinessInspire and Antidote Launch End-to-End Clinical Trial Recruitment Solution to Accelerate Medical ResearchBy Nasdaq OMXJan 4, 2018, 12:00 PM UTC
